Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
2020 · Scientific Reports · 68 citations
https://doi.org/10.1038/s41598-020-74761-y
J
Jianbo Dong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.2K
Citations
20
h-index
32
i10-index
Jianbo Dong is an academic researcher from Alibaba Group (United States). The author has contributed to research in topics: Parallel Computing and Optimization Techniques & Monoclonal and Polyclonal Antibodies Research & Interconnection Networks and Systems. The author has an h-index of 20, co-authored 51 publications.
ORCID: 0000-0003-0939-8943Papers by this author
worksMachine learning-assisted benign transformation of three zinc states in zinc ion batteries
2025 · Energy & Environmental Science · 27 citations
https://doi.org/10.1039/d5ee00650c
First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants
2022 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-022-07952-4
Yeast display libraries constructed and used for BoNT/A LC mAb generation.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0135306.t001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat